Molecular detection and analysis firm Oxford Nanopore Technologies has raised £40m ($64m) in private equity funding from new and existing backers. Founded in 2005, the firm is commercialising a DNA sequencing system which utilises nanopores originally developed at the University of Oxford. Its technologies can be used in DNA sequencing, diagnostics, drug development, biomolecular interaction,…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
